The latest news, announcements and press releases from OBI Pharma.
OBI Pharma (4174.TWO) was invited by the meeting organizer to present two talks, participate in a Plenary Panel, and host a workshop. At the 15th Annual World ADC London 2025, OBI Pharma will showcase its innovative research achievements in the field of Antibody-Drug Conjugates (ADC). As the largest ADC-focused event in Europe, the conference, held in London from 3/3 to 3/6, gathered over 1000 industry experts and featured 110 speakers from academia and industry. The event centered on advancing drug design, optimizing clinical performance, accelerating manufacturing processes, and expanding ADC applications to benefit more patients.
This is the News section of the company profile page for OBI Pharma on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
